NCT02471196 Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02467413 BAC in Patient With Alzheimer's Disease or Vascular Dementia Status WITHDRAWN Phase PHASE2
NCT02462161 Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart Status COMPLETED Phase PHASE1
NCT02460783 Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function Status COMPLETED Phase NA
NCT02438202 Electroconvulsive Therapy for Treatment of Alzheimer´s Disease Status NOT_YET_RECRUITING Phase NA
NCT02434718 Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02431468 A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02423200 Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Status COMPLETED Phase PHASE2
NCT02423122 A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD) Status COMPLETED Phase PHASE2
NCT02418806 Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres Status COMPLETED Phase NA
NCT02403752 Paired Integrative Home Exercise for Seniors With Dementia and Their Caregivers (PairedPLIE) Status COMPLETED Phase NA
NCT02397980 Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia Status UNKNOWN Phase NA
NCT02389413 Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02386306 Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02380703 Aggression Prevention Training for Caregivers of Persons With Dementia (APT) Status COMPLETED Phase NA
NCT02380573 Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease Status COMPLETED Phase PHASE2